Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clodronate + Mitoxantrone/Prednisone in HRMPC
NCT00003232Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Nov 1997
- Primary completion
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bone pain comparing Clodronate Arm with Placebo Arm (2 arms). Primary endpoint: Localized bone pain response. Started Nov 1997; status: completed.
02
Drugs
clodronate
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT00003232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003232.